FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paolo Martini

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Physiology

Co-author Network

Publications

TOP 3
Roberta M Moretti; Stefania Mai; Marina Montagnani Marelli; Maria R Bani; Carmen Ghilardi; Raffaella Giavazzi; Deanne M Taylor; Paolo G V Martini; Patrizia Limonta
Dual targeting of tumor and endothelial cells by gonadotropin-releasing hormone agonists to reduce melanoma angiogenesis.
Paolo G V Martini; Deanne M Taylor; Jadwiga Bienkowska; Jennifer Jackson; Gregory McAllister; Heike Keilhack; Robert K Campbell
Comparative expression analysis of four breast cancer subtypes versus matched normal tissue from the same patients.
Raegan O'Lone; Katrin Knorr; Iris Z Jaffe; Michael E Schaffer; Paolo G V Martini; Richard H Karas; Jadwiga R Bienkowska; Michael Mendelsohn; Ulla Hansen
Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paolo Martini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Roberta M Moretti; Stefania Mai; Marina Montagnani Marelli; Maria R Bani; Carmen Ghilardi; Raffaella Giavazzi; Deanne M Taylor; Paolo G V Martini; Patrizia Limonta
Dual targeting of tumor and endothelial cells by gonadotropin-releasing hormone agonists to reduce melanoma angiogenesis.
Endocrinology 2010;151(10):4643-53.
2008: Paolo G V Martini; Deanne M Taylor; Jadwiga Bienkowska; Jennifer Jackson; Gregory McAllister; Heike Keilhack; Robert K Campbell
Comparative expression analysis of four breast cancer subtypes versus matched normal tissue from the same patients.
The Journal of steroid biochemistry and molecular biology 2008;109(3-5):207-11.
2007: Raegan O'Lone; Katrin Knorr; Iris Z Jaffe; Michael E Schaffer; Paolo G V Martini; Richard H Karas; Jadwiga R Bienkowska; Michael Mendelsohn; Ulla Hansen
Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species.
Molecular endocrinology (Baltimore, Md.) 2007;21(6):1281-96.
2007: Antonia Pravettoni; O Mornati; Paolo G V Martini; M Marino; Alessandra Colciago; Fabio Celotti; Marcella Motta; Paola Negri-Cesi
Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells.
Molecular and cellular endocrinology 2007;263(1-2):46-54.
2005: Marco Muda; Chaomei He; Paolo G V Martini; Tania Ferraro; Sharon Layfield; Deanne Taylor; Colette Chevrier; Rene Schweickhardt; Christie Kelton; Peter L Ryan; Ross A D Bathgate
Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity.
Molecular human reproduction 2005;11(8):591-600.
2005: Vittoria Guerini; Daniela Sau; Eugenia Scaccianoce; PAOLA RUSMINI; Paolo Ciana; Stefano Di Giovine; Paolo G V Martini; Benita S Katzenellenbogen; Luciano Martini; Marcella Motta; Angelo Poletti
The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
Cancer research 2005;65(12):5445-53.
2003: Paolo G V Martini; Benita S Katzenellenbogen
Modulation of estrogen receptor activity by selective coregulators.
The Journal of steroid biochemistry and molecular biology 2003;85(2-5):117-22.
2003: Ramji R Rajendran; Anne C Nye; Jonna Frasor; Rashna D Balsara; Paolo G V Martini; Benita S Katzenellenbogen
Regulation of nuclear receptor transcriptional activity by a novel DEAD box RNA helicase (DP97).
The Journal of biological chemistry 2003;278(7):4628-38.
2001: Paolo G V Martini; Benita S Katzenellenbogen
Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
Endocrinology 2001;142(8):3493-501.
2000: Benita S Katzenellenbogen; I Choi; R Delage-Mourroux; Tracy R Ediger; Paolo G V Martini; MM Montano; Jun Sun; KE Weis; John A Katzenellenbogen
Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
The Journal of steroid biochemistry and molecular biology 2000;74(5):279-85.
2000: R Delage-Mourroux; Paolo G V Martini; I Choi; DM Kraichely; J Hoeksema; Benita S Katzenellenbogen
Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA.
The Journal of biological chemistry 2000;275(46):35848-56.
2000: Paolo G V Martini; R Delage-Mourroux; DM Kraichely; Benita S Katzenellenbogen
Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.
Molecular and cellular biology 2000;20(17):6224-32.
2000: Benita S Katzenellenbogen; MM Montano; Tracy R Ediger; Jun Sun; K Ekena; G Lazennec; Paolo G V Martini; EM McInerney; R Delage-Mourroux; KE Weis; John A Katzenellenbogen
Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Recent progress in hormone research 2000;55():163-93; discussion 194-5.
1999: MM Montano; K Ekena; R Delage-Mourroux; W Chang; Paolo G V Martini; Benita S Katzenellenbogen
An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(12):6947-52.
1998: Paola Negri-Cesi; Angelo Poletti; Alessandra Colciago; P Magni; Paolo G V Martini; Marcella Motta
Presence of 5alpha-reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue.
The Prostate 1998;34(4):283-91.